New Targets in Developing Dementia Treatments

Beyond Amyloid and Tau

Translate to Spanish or other 102 languages!

Recently, this amyloid hypothesis has been questioned, and there has been a huge upsurge in dementia research.  Image for illustration purposes
Recently, this amyloid hypothesis has been questioned, and there has been a huge upsurge in dementia research. Image for illustration purposes

Medical News Today

- Advertisement -

Alzheimer’s disease is the most common form of dementia. Although its exact cause is unknown, for many years scientists have believed that a protein called beta-amyloid was responsible. Recently, this amyloid hypothesis has been questioned, and there has been a huge upsurge in dementia research. Here, we round up the latest findings, look at possible advances in diagnosis, and ask: Where next for Alzheimer’s research and treatment?

To read the full story, follow the link below to Medical News Today:

https://www.medicalnewstoday.com/articles/beyond-amyloid-and-tau-new-targets-in-developing-dementia-treatments

- Advertisement -

Information Source: https://www.medicalnewstoday.com

- Advertisement -
- Advertisement -

- Advertisement -

More Articles

New Blood Test Detects Testicular Cancer Missed by Standard Markers

Mayo Clinic researchers have developed a blood-based method that may help detect germ cell tumors, the most common type of testicular cancer, including cases that do not show up on standard blood tests, according to a study published in Nature Communications.

FDA Unveils Roadmap for Real-Time Clinical Evidence

The U.S. Food and Drug Administration announced two major steps as part of an initiative to advance the implementation of real-time clinical trials (RTCT).

AI’s Role in Accelerating Lyme Disease Treatments

Mega Doctor News by Tufts University Newswire - Tufts University researchers are using AI and...

How to Use a Weighted Vest Without Risking Injury

Mega Doctor News CLEVELAND CLINIC - It seems like weighted vests are all...
- Advertisement -